| ID | 632 |
|---|
| No | 632 |
|---|
| Brand Name | INSPRA 4 MG ORAL GRANULES |
|---|
| Ingredients | MONTELUKAST SODIUM USP EQ.TO MONTELUKAST 4 MG |
|---|
| Dosage Form | POWDER |
|---|
| Primary Packaging | SACHET |
|---|
| Storage | |
|---|
| Shelf Life | 24 MONTHS |
|---|
| Pack Size | BOX OF 14'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | Asthma
Inspra is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric
patients 12 months of age and older.
Exercise-Induced Bronchoconstriction (EIB)
Inspra is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6
years of age and older.
Allergic Rhinitis
Inspra is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of
age and older and perennial allergic rhinitis in patients 6 months of age and older.
|
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | White to off white colored powder |
|---|
| Note | |
|---|
| License Owner | EXAMED CO.,LTD |
|---|
| Manufacturer | MARTIN DOW LTD |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 01 I 5849/25 |
|---|
| FDD Registration Date | 23/01/2025 |
|---|
| Expiry Date | 22/01/2030 |
|---|
